Abiopharma

New Form 8-K - REGENXBIO Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174947 Size: 616 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits